The Invention for Innovation (i4i) Programme funds collaborative projects between NHS, academia, and industry to advance healthcare technologies and benefit patients. It aims to guide innovative medical technologies through development. Projects can last up to 3 years and receive between £170k to £1.9 million in funding. Since 2010, over 100 projects have been funded totaling over £71 million. The application process involves a two-stage peer review and selection criteria focus on technology innovation, health benefits, and commercialization potential.
Floating Offshore Wind Demonstration Programme competition briefing is an opportunity to find more about this funding supporting the development of innovations for the floating offshore wind industry.
SME Funding in Horizon 2020 - Are You Ready?Zaz Ventures
Follow us: @h2020experts
Horizon 2020 Overview: upcoming EC calls, differences with FP7, EUREKA, Eurostars, COSME, new SME Instrument, Fast Track to Innovation
Funding: targeting the right calls, finding the instruments that match your TRL (technology readiness level)
Consortium: building a balanced consortium, find and qualify partners
Application: evaluation criteria, writing tips, common mistakes, ESR (evaluation summary report)
Next Steps: select and apply for proper support to develop your proposal
Floating Offshore Wind Demonstration Programme competition briefing is an opportunity to find more about this funding supporting the development of innovations for the floating offshore wind industry.
SME Funding in Horizon 2020 - Are You Ready?Zaz Ventures
Follow us: @h2020experts
Horizon 2020 Overview: upcoming EC calls, differences with FP7, EUREKA, Eurostars, COSME, new SME Instrument, Fast Track to Innovation
Funding: targeting the right calls, finding the instruments that match your TRL (technology readiness level)
Consortium: building a balanced consortium, find and qualify partners
Application: evaluation criteria, writing tips, common mistakes, ESR (evaluation summary report)
Next Steps: select and apply for proper support to develop your proposal
SMEs Support & Financial Instruments in HORIZON 2020 - J.D Malo - Presentatio...ISERD Israel
Horizon 2020 Launch Event in Israel - Presentation of Jean-David Mשךםת Head of Unit SMEs, Financial- instruments and State Aid, DG Research and Innovation, European Commission
Eurostars is a joint programme supporting R&D performing small and medium sized enterprises (SMEs). It is co-funded from the national budgets of 34 Eurostars countries and by the European Union through Horizon 2020.
Eurostars has been carefully developed to meet the specific needs of SMEs. With its bottom-up approach, it stimulates international collaborative research and innovation projects that will be rapidly commercialised.
Eurostars is an ideal first step in international cooperation, enabling small businesses to realise the many benefits of working beyond national frontiers. Participation in a Eurostars project can become a passport to growth, further innovation, an opening to new global markets and even greater business success.
Propose your project idea: https://www.eurostars-eureka.eu/
An introduction to Horizon 2020 with some further descriptive notes and a rough breakdown of the draft work programmes from a Art, Design and Social Sciences perspective
NHS England share Code4Health ChallengeHANDI HEALTH
The NHS England Open Source Programme is creating a diverse range of solutions to increase choice, improve clinical practice and enhance patient engagement, including EHR, ePrescribing, departmental systems such as electronic observations, ophthalmology and integrated cross community portal solutions.
The basic details of the A4I Round 5 Funding Competition.
This programme aims at helping companies solve existing problems with their products or processes to improve productivity.
Building a Community of Practice for people in charge of HTA disseminationPatrice Chalon
Presentation at the 12th Annual Meeting of the HTAi (Oslo, Norway, June 15-17th, 2015).
Background
EUnetHTA, the European network for Health Technology Assessment has for about a decade comprehensively dealt with various HTA production aspects. However, dissemination of the final HTA report was yet to be addressed. In order to identify best practices in this field, a Community of Practice (CoP) was initiated with the aim of bringing together people in charge of HTA dissemination amongst EUnetHTA members.
Objectives
To describe the building process and first results of the EUnetHTA Community of Practice on dissemination.
Methods
The objective of the CoP was defined by a work-team. Potential participants were identified from all EUnetHTA Partners, and as a first step a webinar was organised to present interested participants with the concept and objective of the CoP. Subsequently, a workshop was organised to share knowledge and plan future activities.
Results
44 people from 25 agencies in 18 countries joined the CoP. Of these, 25 participated in the webinar and confirmed the utility of the CoP. The workshop brought together 17 people and resulted in identification of crucial steps in the HTA dissemination process, knowledge exchange about dissemination actions, and main topics of interest to the CoP. A series of Webinars provided by the CoP members themselves has been set up, two webinars has already been conducted, and a third is planned later this year.
Conclusion
The CoP provides a suited format for formally exchanging information about dissemination of HTA reports and establishing best practices together with peers. Best practices identified through the workshop and the webinars will be compiled in a best practice document. Further activities will be planned in the future, including the consideration of stakeholder involvement.
Competition scope, competition eligibility conditions and application process...KTN
George Papadakis & Victoria Meredith from Innovate UK outline the details of the Digital Security by Design (DSbD) Business-led Demonstrators Phase 1 EOI competition, covering the competition scope, competition eligibility conditions and application process.
Innovation Loans Competition Briefing: April 2021KTN
Find out more about Innovate UK's Innovation Loans for SME businesses looking to scale and grow. KTN is hosting an applicant briefing webinar on Thursday 20th May.
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
SMEs Support & Financial Instruments in HORIZON 2020 - J.D Malo - Presentatio...ISERD Israel
Horizon 2020 Launch Event in Israel - Presentation of Jean-David Mשךםת Head of Unit SMEs, Financial- instruments and State Aid, DG Research and Innovation, European Commission
Eurostars is a joint programme supporting R&D performing small and medium sized enterprises (SMEs). It is co-funded from the national budgets of 34 Eurostars countries and by the European Union through Horizon 2020.
Eurostars has been carefully developed to meet the specific needs of SMEs. With its bottom-up approach, it stimulates international collaborative research and innovation projects that will be rapidly commercialised.
Eurostars is an ideal first step in international cooperation, enabling small businesses to realise the many benefits of working beyond national frontiers. Participation in a Eurostars project can become a passport to growth, further innovation, an opening to new global markets and even greater business success.
Propose your project idea: https://www.eurostars-eureka.eu/
An introduction to Horizon 2020 with some further descriptive notes and a rough breakdown of the draft work programmes from a Art, Design and Social Sciences perspective
NHS England share Code4Health ChallengeHANDI HEALTH
The NHS England Open Source Programme is creating a diverse range of solutions to increase choice, improve clinical practice and enhance patient engagement, including EHR, ePrescribing, departmental systems such as electronic observations, ophthalmology and integrated cross community portal solutions.
The basic details of the A4I Round 5 Funding Competition.
This programme aims at helping companies solve existing problems with their products or processes to improve productivity.
Building a Community of Practice for people in charge of HTA disseminationPatrice Chalon
Presentation at the 12th Annual Meeting of the HTAi (Oslo, Norway, June 15-17th, 2015).
Background
EUnetHTA, the European network for Health Technology Assessment has for about a decade comprehensively dealt with various HTA production aspects. However, dissemination of the final HTA report was yet to be addressed. In order to identify best practices in this field, a Community of Practice (CoP) was initiated with the aim of bringing together people in charge of HTA dissemination amongst EUnetHTA members.
Objectives
To describe the building process and first results of the EUnetHTA Community of Practice on dissemination.
Methods
The objective of the CoP was defined by a work-team. Potential participants were identified from all EUnetHTA Partners, and as a first step a webinar was organised to present interested participants with the concept and objective of the CoP. Subsequently, a workshop was organised to share knowledge and plan future activities.
Results
44 people from 25 agencies in 18 countries joined the CoP. Of these, 25 participated in the webinar and confirmed the utility of the CoP. The workshop brought together 17 people and resulted in identification of crucial steps in the HTA dissemination process, knowledge exchange about dissemination actions, and main topics of interest to the CoP. A series of Webinars provided by the CoP members themselves has been set up, two webinars has already been conducted, and a third is planned later this year.
Conclusion
The CoP provides a suited format for formally exchanging information about dissemination of HTA reports and establishing best practices together with peers. Best practices identified through the workshop and the webinars will be compiled in a best practice document. Further activities will be planned in the future, including the consideration of stakeholder involvement.
Competition scope, competition eligibility conditions and application process...KTN
George Papadakis & Victoria Meredith from Innovate UK outline the details of the Digital Security by Design (DSbD) Business-led Demonstrators Phase 1 EOI competition, covering the competition scope, competition eligibility conditions and application process.
Innovation Loans Competition Briefing: April 2021KTN
Find out more about Innovate UK's Innovation Loans for SME businesses looking to scale and grow. KTN is hosting an applicant briefing webinar on Thursday 20th May.
Presentation by Andy Cairns, Programme Manager, Innovation Agency: Welcome and introduction at the Funding - Liverpool City Region SME workshop on Thursday 7 February 2019 at The Accelerator, Liverpool
The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018.
The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.
Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork
Presentation by Mike Kenny, Associate Commercial Director, Innovation Agency at the Health Sector Business Breakfast, 16 March at Northwich Memorial Court
Agri-Tech Catalyst Round 10 - Food Systems and NutritionKTN
Open to UK and African organisations who want to collaborate on an Agri-Tech project around food chain innovation in Africa.
Are you working on Agri-Tech innovation and would like to implement some of your ideas in Africa?
If so, you could get funding thanks to the Agri-Tech Catalyst Competition, Round 10, opening on 20 July.
The funding available through the competition is for Agri-Tech projects on food chain innovations in Africa. These projects need to be delivered by a UK and an African organisation working together.
Find out more here: https://ktn-uk.co.uk/news/agri-tech-catalyst-competition-round-10
Transforming Foundation Industries - Investor Partnership Launch EventKTN
At this launch event, held by KTN on 23rd March 2021, attendees found out about the TFI Investor Partner Programme, met the investors and discovered what investors are looking for.
SBRI challenge - changing behaviour to reduce the impact of obesity and alcoh...NHS London
Slides describing the SBRI challenge on changing behaviour to reduce the impact of obesity and alcohol related disease. For more info see http://www.london.nhs.uk/sbri
Open to UK and African organisations who want to collaborate on an Agri-Tech project around food chain innovation in Africa.
Are you working on Agri-Tech innovation and would like to implement some of your ideas in Africa?
If so, you could get funding thanks to the Agri-Tech Catalyst Competition, Round 10, opening on 20 July.
The funding available through the competition is for Agri-Tech projects on food chain innovations in Africa. These projects need to be delivered by a UK and an African organisation working together.
Find out more here: https://ktn-uk.co.uk/news/agri-tech-catalyst-competition-round-10
Open to UK and African organisations who want to collaborate on an Agri-Tech project around food chain innovation in Africa.
Are you working on Agri-Tech innovation and would like to implement some of your ideas in Africa?
If so, you could get funding thanks to the Agri-Tech Catalyst Competition, Round 10, opening on 20 July.
The funding available through the competition is for Agri-Tech projects on food chain innovations in Africa. These projects need to be delivered by a UK and an African organisation working together.
Find out more here: https://ktn-uk.co.uk/news/agri-tech-catalyst-competition-round-10
Transforming Food Production Briefing Event for UK-China Bilateral - Precisio...KTN
A component of the ISCF Transforming Food Production (TFP) is the International activities based on bilateral agreements to ensure new technologies take advantage of overseas markets. UK businesses can apply for a share of up to £5 million to work with Chinese partners to develop new integrated precision farming technology and help achieve net-zero emissions. This funding is from the Industrial Strategy Challenge Fund.
The aim of this competition is to encourage the use of data-intensive methods for commercial farming.
Find out more: https://ktn-uk.co.uk/news/live-now-webcast-transforming-food-production-briefing-event-for-uk-china-bilateral
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
2. To advance the translation of healthcare technologies for increased patient benefit through guided progression of innovative medical technologies.
Programme objectives
3. Types of projects
A low-cost non-invasive visual aid for severely sight-impaired individuals
Next Generation Mobile HIV Diagnostics with Wireless Connectivity
4. Types of projects
Stroke reduction via improved opportunistic screening for atrial fibrillation - An evaluation of the clinical and economic benefits of the RapidRhythm device within primary care
5. Facts and Figures
•Funding: £4 million in 2006/07; £20 million in 2014/15
•Projects last up to 3 years
•Current awards range from £170k up to £1.9 million but no formal limit
•Since 2010, 102 projects recommended for funding, totalling £71,454,794
6. Project team eligibility
•Must be collaborative - Minimum of two organisations
•NHS Trust, Higher Education Institution or industry
•SMEs are particularly welcome
•Lead applicants must be based in England or Wales only
7. 3 key points...
•The benefits to patients and the NHS must be clearly articulated
•Applications must show a high degree of technological innovation
•The project team must contain the appropriate expertise for the work to be undertaken.
8. Application process
Stage 1
•Sift for eligibility
•Assessed by Panel members
Sub-Panel
•Includes Programme Director, Chairs and Deputy Chairs
•Shortlist to invite to Stage 2
Stage 2
•Peer review, including lay review
•Due diligence begins
Panel
•Risk friendly, multidisciplinary Panel
•Presentations and Q&A
9. Selection criteria
•Demonstrable evidence that a novel technology or intervention will be the ultimate output of the research and will deliver benefits to patients
•Relevance of the research topic to the needs of the NHS and patients
•Strength of the research / management team
•The degree of technological innovation and the case for further development
•The health economic case
•The strength of the overall business/commercialisation plan
•The quality of the outline and full applications
10. 2014 Calls – key dates
9th call for i4i Product Development Awards
Call opens November 2014
4th call for i4i Challenge Awards
Call opens November 2014
11. Beyond the Panel
•Due diligence
–Includes understanding IP position
–Aimed at encouraging success
•Project milestones
–All projects are contracted against milestones
–Agreed with project team and CCF
•Monitoring
–Active monitoring against milestones
–Regular technical & financial reporting
–Site visits, advice, RSGs, IPMG